1.2500
-0.0400
(-3.10%)
收市：January 31 at 3:55:57 PM EST
內部人士陣容
內幕名冊數據僅來自最近 24 個月美國證券交易委員會 (SEC) 申報文件表格 3 及表格 4。
| 個人或機構 | 最近一次交易 | 日期 | 成交日期截止前持股股數 |
|---|---|---|---|
| ANTIBODY INVESTMENTS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 13, 2018 | -- |
| FRIEBERG JACOB B Director | Stock Award(Grant) | Nov 23, 2022 | -- |
| FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Nov 14, 2024 | -- |
| LEONARD JOHN E Officer | Conversion of Exercise of derivative security | Jul 27, 2020 | 2,014 |
| ROYER SCOTT E Chief Financial Officer | Conversion of Exercise of derivative security | Sep 3, 2020 | 4,499 |
| VAN STRYDONCK GERALD E Director | Stock Award(Grant) | May 10, 2024 | 543 |
| ZAUDERER MAURICE Chief Executive Officer | Stock Award(Grant) | Nov 14, 2024 | -- |
相關股票代號
ENTX Entera Bio Ltd.
2.1900
-6.01%
THAR Tharimmune, Inc.
1.9600
+0.51%
ENTO Entero Therapeutics, Inc.
0.4983
-0.32%
ARTL Artelo Biosciences, Inc.
1.2000
+0.84%
ACHL Achilles Therapeutics plc
1.1300
+1.80%
SNGX Soligenix, Inc.
2.3300
+0.87%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
MGTX MeiraGTx Holdings plc
6.29
-2.18%
ADIL Adial Pharmaceuticals, Inc.
0.8300
0.00%